Semaglutide was linked to greater weight loss and a 15% lower fracture risk in people with type 2 diabetes, raising the possibility of an unexpected bone health benefit. People with type 2 diabetes who took semaglutide experienced greater weight loss and a lower risk of bone fractures than those using several other weight-loss medications, according [...]

People taking popular GLP-1 weight-loss drugs like Ozempic, Wegovy, Mounjaro, and Zepbound may be shedding pounds, but a new study suggests they are also moving less. People with obesity who lost weight while taking popular medications such as Ozempic, Wegovy, Zepbound, and similar drugs became significantly less physically active, according to research presented at ENDO [...]